How Clarity’s Cu-64 SAR-bisPSMA Doubled Prostate Cancer Lesion Detection

• Cu-64 SAR-bisPSMA detected 2.6 times more lesions per patient than Ga-68 PSMA-11
• 78% of patients had positive scans with Cu-64 SAR-bisPSMA versus 36% with Ga-68 PSMA-11
• Patient management changed in 44% of cases after Cu-64 SAR-bisPSMA imaging
• Data accepted for oral presentation at the 2026 European Association of Urology Congress